Allergan’s €2.7 Billion Registered Fixed and Floating Rate Notes Offering

Cravath represented the underwriters, led by Morgan Stanley, Barclays, BNP Paribas, HSBC, Bank of America Merrill Lynch, Citigroup and Mizuho Securities, in connection with the €2.7 billion registered fixed and floating rate notes offering of Allergan Funding SCS, an indirect wholly owned subsidiary of Allergan plc, formerly known as Actavis plc, a global specialty pharmaceutical company. The notes were listed on the New York Stock Exchange. The transaction closed on May 26, 2017.

The Cravath team included partner Andrew J. Pitts and associates Mark Mushkin, Trevor C. Lynch and Rami Totari.